Leslie M. Randall, MD, MAS, discusses patient-reported outcomes from the ENGOT-cx11/GOG 3047/KEYNOTE-A18 trial in locally advanced cervical cancer.
Leslie M. Randall, MD, MAS
Advertisement
Articles by Leslie M. Randall, MD, MAS
Leslie M. Randall, MD, MAS, discusses the unmet needs in platinum-resistant ovarian cancer.
Advertisement
Latest Updated Articles
Dr. Randall on Unmet Needs in Platinum-Resistant Ovarian CancerNovember 17th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
2
Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC
3
Daraxonrasib Yields Durable Responses in Previously Treated RAS-Mutant NSCLC
4
Novel Therapies Are Poised to Answer Questions and Reinvigorate Hematologic Oncology at SOHO 2026
5